Visible red light does not induce DNA damage in human dermal fibroblasts

Area of Science:

• Dermatology
• Photobiology
• Cellular Biology

Background:

• Visible red light (RL) therapy is increasingly used for skin conditions like acne, psoriasis, and wounds.
• Previous research indicates RL generates reactive oxygen species (ROS) in human dermal fibroblasts (HDFs).
• Other light sources (UV, blue light) are known to cause ROS and DNA damage in fibroblasts.

Purpose of the Study:

• To investigate if high fluences of visible red light induce DNA damage in human dermal fibroblasts.
• To determine if RL exposure leads to DNA damage via ROS or other mechanisms.

Main Methods:

• Human dermal fibroblasts (HDFs) were exposed to varying fluences of red light (633 nm).
• DNA damage was assessed by measuring cyclobutane pyrimidine dimers (CPD) and 6-4 photoproducts (6-4PP).
• Damage assessment occurred immediately, 3 hours, and 24 hours post-irradiation.

Main Results:

• High fluences of red light (320 J/cm², 640 J/cm², 1280 J/cm²) did not significantly increase DNA damage markers (CPD, 6-4PP).
• No measurable DNA damage was observed at any time point following RL irradiation.
• These findings indicate RL does not induce genotoxicity in HDFs.

Conclusions:

• Visible red light therapy at the tested fluences does not induce DNA damage in human skin fibroblasts.
• The study supports the safety profile of red light therapy for dermatological applications.
• Further research can build upon these findings to confirm RL safety in various skin conditions.